Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cunningham

Showing results (11-20 of 1,100) with videos related to

Pageof 110
Sort By:
BMJ (Clinical Research Ed.)|December 16, 1989
Cytotoxic drugs for gastric and colorectal cancerD Cunningham
Seminars in Oncology|April 23, 1999
Setting a new standard--irinotecan (Campto) in the second-line therapy of colorectal cancer: final results of two phase III studies and implications for clinical practiceD Cunningham
Journal of the Royal College of Physicians of London|January 7, 2000
Government directives and changes: the potential impact on clinical practiceD Cunningham
Nuclear Medicine Communications|May 1, 1995
Other imaging in bony metastasesD Cunningham
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovationD Cunningham
Lancet (London, England)|January 1, 1983
Whooping cough in West LondonD Cunningham
Clinical Cardiology|July 1, 1991
High-energy catheter ablation of cardiac arrhythmias: an outmoded technique in the 1990sD Cunningham
Tumori|January 1, 1997
Efficacy and tolerability of a new inhibitor of thymidylate synthase: 'Tomudex' (raltitrexed)D Cunningham
Health Marketing Quarterly|December 6, 1985
Community education as a marketing tool for your hospitalD Cunningham
Journal of Hazardous Materials|September 9, 2000
IPPC, BAT, and voluntary agreementsD Cunningham
Pageof 110

Showing results (11-20 of 1,100) with videos related to

Sort By:
Pageof 110
BMJ (Clinical Research Ed.)|December 16, 1989
Cytotoxic drugs for gastric and colorectal cancerD Cunningham
Seminars in Oncology|April 23, 1999
Setting a new standard--irinotecan (Campto) in the second-line therapy of colorectal cancer: final results of two phase III studies and implications for clinical practiceD Cunningham
Journal of the Royal College of Physicians of London|January 7, 2000
Government directives and changes: the potential impact on clinical practiceD Cunningham
Nuclear Medicine Communications|May 1, 1995
Other imaging in bony metastasesD Cunningham
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovationD Cunningham
Lancet (London, England)|January 1, 1983
Whooping cough in West LondonD Cunningham
Clinical Cardiology|July 1, 1991
High-energy catheter ablation of cardiac arrhythmias: an outmoded technique in the 1990sD Cunningham
Tumori|January 1, 1997
Efficacy and tolerability of a new inhibitor of thymidylate synthase: 'Tomudex' (raltitrexed)D Cunningham
Health Marketing Quarterly|December 6, 1985
Community education as a marketing tool for your hospitalD Cunningham
Journal of Hazardous Materials|September 9, 2000
IPPC, BAT, and voluntary agreementsD Cunningham
Pageof 110